Merck· @Merck · X·· 2026-06-24精选AI 评分62
AI 导读
欧盟委员会批准一款新的联合疗法，用于部分肌层浸润性膀胱癌（MIBC）患者。该疗法由默沙东与辉瑞、安斯泰来合作提供，默沙东称其针对该患者群体一项重要的未满足需求。
推荐理由
欧盟委员会批准肌层浸润性膀胱癌新联合疗法，读者可了解该适应症治疗选择的变化。
正文
Today, the European Commission approved a new treatment combination for certain patients with muscle-invasive #BladderCancer (MIBC). Together with Pfizer and Astellas Pharma, we’re proud to provide a treatment poised to address an important unmet need for these patients. Learn more: http://go.merck.com/~1li
来源：Merck · x.com